check_circleStudy Completed

Fever, Migraine, Pain

BAY81-8781 Thrombocyte inhibition, pharmacokinetics

Trial purpose

Primary Objective:
To investigate the function of platelets after different single doses of
acetylsalicylic acid (ASA) given as intravenous (IV) BAY 81-8781 and
Aspirin® tablets in comparison to inactive intravenous (IV) treatment.

Secondary Objective:
To investigate safety, tolerability, and pharmacokinetics of these
treatments.

Key Participants Requirements

Sex

N/A

Age

40 - 58 Years
  • -

  • -

Trial summary

Enrollment Goal
22
Trial Dates
July 2006 - December 2006
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Aspirin (Acetylsalicylic Acid, BAY81-8781)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
Wuppertal, 42096, Germany

Trial design

Randomized, open-label, six-fold cross-over study to investigate the pharmacodynamic effect on thrombocytes and the safety, tolerability and pharmacokinetics of acetylsalicylic acid after single intravenous doses of BAY 81-8781 and oral doses of Aspirin plain tablets in 24 healthy male and female subjects
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
Randomized
Blinding
N/A
Assignment
Crossover Assignment
Trial Arms
N/A